中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 38 Issue 1
Jan.  2022
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2022  >  38(1): 124-128

Effect of ideal cardiovascular health metrics on the incidence rate of nonalcoholic fatty liver disease

DOI: 10.3969/j.issn.1001-5256.2022.01.019
  • 1.

    Operating Room of Kailuan General Hospital, Tangshan, Hebei 063000, China

  • 2.

    Graduate School of North China University of Science and Technology, Tangshan, Hebei 063000, China

  • 3.

    Operating Room of Tangshan Central Hospital, Tangshan, Hebei 063000, China

Research funding:

Medical Science Research Program of Hebei Province in 2020 (20201285)

  • Received Date: 2021-06-05
  • Accepted Date: 2021-07-02
  • Published Date: 2022-01-20
    Abstract
  •   Objective  To investigate the association of ideal cardiovascular health metrics with the incidence rate of nonalcoholic fatty liver disease (NAFLD), and to provide a basis for the prevention and control of NAFLD.  Methods  A prospective cohort study was conducted for the data of 50 511 employees of Kailuan Group who participated in physical examination from July 2006 to June 2007, and the onset of NAFLD was observed during follow-up once every two years. A one-way analysis of variance was used for comparison of normally distributed continuous data between multiple groups, and the Kruskal-Wallis H test used for comparison of continuous data with skewed distribution between multiple groups; the chi-square test was used for comparison of categorical data between groups. The subjects were divided into four groups according to the quartile of cardiovascular health score (CHS), and person-year incidence rate was used to calculate the incidence rate of NAFLD in each group. Restricted cubic spline (RCS) curve was used to calculate the dose-response relation between continuous variables and outcome events; the Cox proportional hazards model was used to analyze hazard ratio (HR) and 95% confidence interval (CI) in each group and investigate the effect of ideal cardiovascular health metrics on the incidence rate of NAFLD.  Results  During the mean follow-up time of 5.58 years, a total of 15 265 cases of NAFLD were observed, and the incidence rate of NAFLD was 77.88/1000 person-year in the Q1 group, 61.33/1000 person-year in the Q2 group, 46.37/1000 person-year in the Q3 group, and 33.69/1000 person-year in the Q4 group. RCS results showed a non-linear relationship between CHS continuous variable and the risk of NAFLD (P < 0.05). The multivariate Cox proportional risk model analysis showed that compared with the Q1 group in terms of the risk of NAFLD, the Q2, Q3, and Q4 groups had an HR of 0.78 (95%CI 0.74~0.81), 0.57 (95%CI 0.54~0.59), and 0.38 (95%CI 0.36~0.41), respectively, and similar results were observed in subjects stratified by sex and age. The analysis of each component showed that ideal body mass index (HR=0.37, 95%CI: 0.36~0.39), ideal blood glucose (HR=0.80, 95%CI: 0.77~0.84), ideal blood pressure (HR=0.72, 95%CI: 0.69~0.75), ideal cholesterol (HR=0.86, 95%CI: 0.83~0.89), and ideal diet (HR=0.94, 95%CI: 0.90~0.99) were protective factors against NAFLD.  Conclusion  Ideal cardiovascular health metrics are protective factors against NAFLD, and maintaining a healthy lifestyle may help to prevent the onset of NAFLD.

     

    • FullText(HTML)
  • loading
    • References(17)
  • [1]
    GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: A systematic analysis for the Global Burden of Disease Study 2015[J]. Lancet, 2016, 388(10053): 1459-1544. DOI: 10.1016/S0140-6736(16)31012-1.
    [2]
    BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. DOI: 10.3322/caac.21492.
    [3]
    LLOYD-JONES DM, HONG Y, LABARTHE D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: The American Heart Association's strategic Impact Goal through 2020 and beyond[J]. Circulation, 2010, 121(4): 586-613. DOI: 10.1161/CIRCULATIONAHA.109.192703.
    [4]
    EFFOE VS, CARNETHON MR, ECHOUFFO-TCHEUGUI JB, et al. The American Heart Association Ideal Cardiovascular Health and Incident type 2 diabetes mellitus among blacks: The Jackson Heart Study[J]. J Am Heart Assoc, 2017, 6(6): e005008. DOI: 10.1161/JAHA.116.005008.
    [5]
    HOU J, LI J, HUANG J, et al. Relationship between the exposure to cumulative cardiovascular health behaviors and factors and chronic kidney disease-The Kailuan study[J]. PLoS One, 2018, 13(8): e0203171. DOI: 10.1371/journal.pone.0203171.
    [6]
    RASMUSSEN-TORVIK LJ, SHAY CM, ABRAMSON JG, et al. Ideal cardiovascular health is inversely associated with incident cancer: The Atherosclerosis Risk In Communities study[J]. Circulation, 2013, 127(12): 1270-1275. DOI: 10.1161/CIRCULATIONAHA.112.001183.
    [7]
    ZHU S, SHI J, JI C, et al. Association of the ideal cardiovascular behaviors and factors with the incidence of nonalcoholic fatty liver disease: A prospective study[J]. Eur J Gastroenterol Hepatol, 2018, 30(5): 578-582. DOI: 10.1097/MEG.0000000000001069.
    [8]
    CUI HZ, MA XM, LIU Q. Influence of the interaction between abdominal obesity and hypertriglyceridemia on the development of nonalcoholic fatty liver disease[J]. J Clin Hepatol, 2020, 36(6): 1314-1319. DOI: 10.3969/j.issn.1001-5256.2020.06.025.

    崔皓哲, 马向明, 刘倩, 等. 腹型肥胖与甘油三酯的交互作用对非酒精性脂肪性肝病发病的影响[J]. 临床肝胆病杂志, 2020, 36(6): 1314-1319. DOI: 10.3969/j.issn.1001-5256.2020.06.025.
    [9]
    National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association: Fatty Liver Expert Committee, Chinese Medical Doctor Association. Guidelines of prevention and treatment for nonalcoholic fatty liver disease: A 2018 update[J]. J Clin Hepatol, 2018, 34(5): 947-957. DOI: 10.3969/j.issn.1001-5256.2018.05.007.

    中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 非酒精性脂肪性肝病防治指南(2018年更新版)[J]. 临床肝胆病杂志, 2018, 34(5): 947-957. DOI: 10.3969/j.issn.1001-5256.2018.05.007.
    [10]
    HU DY, MA CS. Practice of cardiology 2010: Standardized treatment[M]. Beijing: People's Medical Publishing House, 2010: 10-14.

    胡大一, 马长生. 心脏病学实践2010——规范化治疗[M]. 北京: 人民卫生出版社, 2010: 10-14.
    [11]
    SHI JH, HAO YH, WU SL, et al. The prevalence and distribution of ideal cardiovascular health behavior in employees of Kailuan Group cohort[J]. Chin J Cardiol, 2012, 40(1): 62-67. DOI: 10.3760/cma.j.issn.0253-3758.2012.01.013.

    施继红, 郝雁红, 吴寿岭, 等. 开滦研究人群理想心血管健康行为和因素分布调查[J]. 中华心血管病杂志, 2012, 40(1): 62-67. DOI: 10.3760/cma.j.issn.0253-3758.2012.01.013.
    [12]
    ZHU NB, ZHOU M, YU CQ, et al. Prevalence of healthy life style in Chinese adults[J]. Chin J Epidemiol, 2019, 40(2): 136-141. DOI: 10.3760/cma.j.issn.0254-6450.2019.02.003.

    祝楠波, 周密, 余灿清, 等. 中国成年人健康生活方式状况分析[J]. 中华流行病学杂志, 2019, 40(2): 136-141. DOI: 10.3760/cma.j.issn.0254-6450.2019.02.003.
    [13]
    WANG L, LI M, ZHAO Z, et al. Ideal cardiovascular health is inversely associated with nonalcoholic fatty liver disease: A prospective analysis[J]. Am J Med, 2018, 131(12): 1515. e1-1515. e10. DOI: 10.1016/j.amjmed.2018.07.011.
    [14]
    LIU H, YAO Y, WANG Y, et al. Ideal cardiovascular health metrics and the risk of non-alcoholic fatty liver disease: A cross-sectional study in northern China[J]. Liver Int, 2019, 39(5): 950-955. DOI: 10.1111/liv.14060.
    [15]
    JANG EH, CHANG Y, RYU S, et al. Cardiovascular health metrics in the development and regression of nonalcoholic fatty liver disease: A cohort study[J]. J Clin Med, 2019, 8(5): 610. DOI: 10.3390/jcm8050610.
    [16]
    FARZANEGI P, DANA A, EBRAHIMPOOR Z, et al. Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): Roles of oxidative stress and inflammation[J]. Eur J Sport Sci, 2019, 19(7): 994-1003. DOI: 10.1080/17461391.2019.1571114.
    [17]
    SHEN X, JIN C, WU Y, et al. Prospective study of perceived dietary salt intake and the risk of non-alcoholic fatty liver disease[J]. J Hum Nutr Diet, 2019, 32(6): 802-809. DOI: 10.1111/jhn.12674.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(3)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (538) PDF downloads(43) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return